Health
Results: 697-708 of 8672

Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG

Orexo changes the organizational structure and management team to increase focus on development of new products

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio






